Tracy TS and Johns M |
Comment: delirium probably induced by clarithromycin in a patient receiving fluoxetine. |
1996 |
Ann Pharmacother |
pmid:8893135
|
Wintermeyer SM et al. |
Dirithromycin: a new macrolide. |
1996 |
Ann Pharmacother |
pmid:8893122
|
Hunt Gerardo S et al. |
Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891154
|
Patel KB et al. |
Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891147
|
Tateda K et al. |
Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891128
|
Giacometti A et al. |
In-vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine against Cryptosporidium parvum. |
1996 |
J. Antimicrob. Chemother. |
pmid:8889715
|
Tursi A et al. |
One-week low-dose triple therapy vs. two-week medium-dose double therapy for H.pylori infection. |
1996 Jul-Aug |
Hepatogastroenterology |
pmid:8884304
|
Ji B et al. |
Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacin, against Mycobacterium leprae in patients. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8878595
|
Pankuch GA et al. |
MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8878583
|
Wenisch C et al. |
Effect of single oral dose of azithromycin, clarithromycin, and roxithromycin on polymorphonuclear leukocyte function assessed ex vivo by flow cytometry. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8878577
|
McLinn S and Williams D |
Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media. |
1996 |
Pediatr. Infect. Dis. J. |
pmid:8878239
|
Thor P et al. |
Dysfunction in gastric myoelectric and motor activity in Helicobacter pylori positive gastritis patients with non-ulcer dyspesia. |
1996 |
J. Physiol. Pharmacol. |
pmid:8877902
|
Tursi A et al. |
Helicobacter pylori eradication helps resolve pyloric and duodenal stenosis. |
1996 |
J. Clin. Gastroenterol. |
pmid:8877648
|
Dhaenens L et al. |
In-vitro activities of clarithromycin and other antimicrobial agents against Helicobacter pylori isolated from children. |
1996 |
J. Antimicrob. Chemother. |
pmid:8877551
|
Fisher M et al. |
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group. |
1996 |
Int J STD AIDS |
pmid:8876354
|
Yousfi MM et al. |
Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy). |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8871452
|
Ferguson PJ and Saulsbury FT |
Successful treatment of chronic Mycobacterium abscessus otitis media with clarithromycin. |
1996 |
Pediatr. Infect. Dis. J. |
pmid:8866816
|
Xu G et al. |
Effect of macrolide antibiotics on macrophage functions. |
1996 |
Microbiol. Immunol. |
pmid:8865152
|
Hackelsberger A and Malfertheiner P |
A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection. |
1996 |
Drug Saf |
pmid:8862962
|
Chiba N |
Omeprazole and clarithromycin with and without metronidazole for the eradication of Helicobacter pylori. |
1996 |
Am. J. Gastroenterol. |
pmid:8855737
|
Schimkat M et al. |
Rifabutin-associated anterior uveitis in patients infected with human immunodeficiency virus. |
1996 |
Ger J Ophthalmol |
pmid:8854102
|
Yousfi MM et al. |
One-week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8853767
|
Cone LA et al. |
Mania due to clarithromycin therapy in a patient who was not infected with human immunodeficiency virus. |
1996 |
Clin. Infect. Dis. |
pmid:8853002
|
Dammann HG |
[Helicobacter pylori eradication: triple therapy versus dual therapy]. |
1996 |
Fortschr. Med. |
pmid:8852685
|
Vermot D et al. |
Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8851620
|
Amsden GW |
Erythromycin, clarithromycin, and azithromycin: are the differences real? |
1996 Jan-Feb |
Clin Ther |
pmid:8851453
|
O'Hara K and Yamamoto K |
Reaction of roxithromycin and clarithromycin with macrolide-inactivating enzymes from highly erythromycin-resistant Escherichia coli. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8849224
|
Liviu L et al. |
Pancreatitis induced by clarithromycin. |
1996 |
Ann. Intern. Med. |
pmid:8849171
|
Ednie LM et al. |
Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843313
|
Rana KZ et al. |
Clarithromycin does not affect phosphorylation of zidovudine in vitro. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843311
|
Alper CM et al. |
Efficacy of clarithromycin treatment of acute otitis media caused by infection with penicillin-susceptible, -intermediate, and -resistant Streptococcus pneumoniae in the chinchilla. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843299
|
Heifets L |
Susceptibility testing of Mycobacterium avium complex isolates. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843278
|
Yousfi MM et al. |
Resolution of a metaplastic duodenal polyp after cure of Helicobacter pylori infection. |
1996 |
J. Clin. Gastroenterol. |
pmid:8835902
|
Versalovic J et al. |
Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834903
|
Dattwyler RJ et al. |
Clarithromycin in treatment of early Lyme disease: a pilot study. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834900
|
Ji B et al. |
How effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice? |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834894
|
Yamamoto T et al. |
Activity of KRM-1648 alone or in combination with both ethambutol and kanamycin or clarithromycin against Mycobacterium intracellulare infections in beige mice. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834892
|
Ji B et al. |
Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834886
|
Vangala R and Cernek PK |
Hypersensitivity reaction to clarithromycin. |
1996 |
Ann Pharmacother |
pmid:8833572
|
Erah PO et al. |
Ion-pair high-performance liquid chromatographic assay method for the assessment of clarithromycin stability in aqueous solution and in gastric juice. |
1996 |
J. Chromatogr. B, Biomed. Appl. |
pmid:8832427
|
Piersimoni C et al. |
Activity of seven antimicrobial agents, alone and in combination, against AIDS-associated isolates of Mycobacterium avium complex. |
1995 |
J. Antimicrob. Chemother. |
pmid:8830013
|
Webb DD |
Practice guidelines for treatment of peptic ulcer disease. |
1996 |
JAMA |
pmid:8827959
|
Pijpers E et al. |
A clarithromycin-induced myasthenic syndrome. |
1996 |
Clin. Infect. Dis. |
pmid:8824993
|
Xu G et al. |
[Effect of clarithromycin on cytocidal activity against Pseudomonas aeruginosa in mice peritoneal cavity]. |
1996 |
Kansenshogaku Zasshi |
pmid:8822058
|
Nishi K et al. |
[Effect of clarithromycin on symptoms and mucociliary transport in patients with sino-bronchial syndrome]. |
1995 |
Nihon Kyobu Shikkan Gakkai Zasshi |
pmid:8821993
|
Sketris IS et al. |
Possible role of the intestinal P-450 enzyme system in a cyclosporine-clarithromycin interaction. |
1996 Mar-Apr |
Pharmacotherapy |
pmid:8820476
|
Nash KA and Inderlied CB |
Rapid detection of mutations associated with macrolide resistance in Mycobacterium avium complex. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807078
|
Gillum JG et al. |
Effect of combination therapy with ciprofloxacin and clarithromycin on theophylline pharmacokinetics in healthy volunteers. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807068
|
Wallace RJ et al. |
Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807061
|
Conte JE et al. |
Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807050
|